Summary
Gene transfer into mammalian cells has been of crucial importance for studies determining the role of specific genes in the differentiation and cell fate of various hematopoietic lineages. Until recently, the majority of these studies were performed in transformed cell lines due to difficulties in achieving levels of transfection of greater than 1–3% in primary hematopoietic cells. Vectors based on retrovirus and lentivirus backbones have revolutionized our ability to transfer genes into primary hematopoietic cells. These vectors have allowed extensive ex vivo and in vivo studies following introduction of a gene of interest and have been used clinically in individuals suffering from cancers, infections, and genetic diseases. Ex vivo lentiviral gene transfer can result in efficient transduction of progenitor cells (>80%) that can then be further differentiated into immune lineage cells including T, B, dendritic, or natural killer cells. Alternatively, differentiated immune cells can themselves be transduced ex vivo with lentiviral vectors. Here, we discuss optimization of technologies for human immunodeficiency virus (HIV)-based gene transfer into murine and human progenitor and immune cell lineages.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Naldini, L., U. Blomer, P. Gallay, D. Ory, R. Mulligan, F.H. Gage, I.M. Verma and D. Trono. 1996. In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science 272:263–267.
Delenda, C. 2004. Lentiviral vectors: optimization of packaging, transduction and gene expression. J Gene Med 6 Suppl 1:S125–S138.
Sinn, P.L., S.L. Sauter and P.B. McCray, Jr. 2005. Gene therapy progress and prospects: development of improved lentiviral and retroviral vectors – design, biosafety, and production. Gene Ther 12:1089–1098.
Zennou, V., C. Petit, D. Guetard, U. Nerhbass, L. Montagnier and P. Charneau. 2000. HIV-1 genome nuclear import is mediated by a central DNA flap. Cell 101:173–185.
Follenzi, A., L.E. Ailles, S. Bakovic, M. Geuna and L. Naldini. 2000. Gene transfer by lentiviral vectors is limited by nuclear translocation and rescued by HIV-1 pol sequences. Nat Genet 25:217–222.
Dardalhon, V., B. Herpers, N. Noraz, F. Pflumio, D. Guetard, C. Leveau, A. Dubart-Kupperschmitt, P. Charneau, et al. 2001. Lentivirus-mediated gene transfer in primary T cells is enhanced by a central DNA flap. Gene Ther 8:190–198.
Sirven, A., F. Pflumio, V. Zennou, M. Titeux, W. Vainchenker, L. Coulombel, A. Dubart-Kupperschmitt and P. Charneau. 2000. The human immunodeficiency virus type-1 central DNA flap is a crucial determinant for lentiviral vector nuclear import and gene transduction of human hematopoietic stem cells. Blood 96: 4103–4110.
Manganini, M., M. Serafini, F. Bambacioni, C. Casati, E. Erba, A. Follenzi, L. Naldini, S. Bernasconi, et al. 2002. A human immunodeficiency virus type 1 pol gene-derived sequence (cPPT/CTS) increases the efficiency of transduction of human nondividing monocytes and T lymphocytes by lentiviral vectors. Hum Gene Ther 13:1793–1807.
Zufferey, R., T. Dull, R.J. Mandel, A. Bukovsky, D. Quiroz, L. Naldini, D. Trono and D. Nagy. 1998. Self-inactivating lentivirus vector for safe and efficient in vivo gene delivery. J Virol 72:9873–9880.
Ramezani, A., T.S. Hawley and R.G. Hawley. 2003. Performance- and safety-enhanced lentiviral vectors containing the human interferon-beta scaffold attachment region and the chicken beta-globin insulator. Blood 101:4717–4724.
Rivella, S., J.A. Callegari, C. May, C.W. Tan and M. Sadelain. 2000. The cHS4 insulator increases the probability of retroviral expression at random chromosomal integration sites. J Virol 74:4679–4687.
Zufferey, R., D. Nagy, R.J. Mandel, L. Naldini and D. Trono. 1997. Multiply attenuated lentiviral vector achieves efficient gene delivery in vivo. Nat Biotechnol 15:871–875.
Chinnasamy, D., N. Chinnasamy, M.J. Enriquez, M. Otsu, R.A. Morgan and F. Candotti. 2000. Lentiviral-mediated gene transfer into human lymphocytes: role of HIV-1 accessory proteins. Blood 96:1309–1316.
Cui, Y., J. Golob, E. Kelleher, Z. Ye, D. Pardoll and L. Cheng. 2002. Targeting transgene expression to antigen-presenting cells derived from lentivirus-transduced engrafting human hematopoietic stem/progenitor cells. Blood 99:399–408.
May, C., S. Rivella, J. Callegari, G. Heller, K.M. Gaensler, L. Luzzatto and M. Sadelain. 2000. Therapeutic haemoglobin synthesis in beta-thalassaemic mice expressing lentivirus-encoded human beta-globin. Nature 406:82–86.
Adjali, O., G. Marodon, M. Steinberg, C. Mongellaz, V. Thomas-Vaslin, C. Jacquet, N. Taylor and D. Klatzmann. 2005. In vivo correction of ZAP-70 immunodeficiency by intrathymic gene transfer. J Clin Invest 115:2287–2295.
Verhoeyen, E. and F.L. Cosset. 2004. Surface-engineering of lentiviral vectors. J Gene Med 6 Suppl 1:S83–S94.
Verhoeyen, E., V. Dardalhon, O. Ducrey-Rundquist, D. Trono, N. Taylor and F.L. Cosset. 2003. IL-7 surface-engineered lentiviral vectors promote survival and efficient gene transfer in resting primary T lymphocytes. Blood 101:2167–2174.
Sandrin, V., B. Boson, P. Salmon, W. Gay, D. Negre, R. Le Grand, D. Trono and F.L. Cosset. 2002. Lentiviral vectors pseudotyped with a modified RD114 envelope glycoprotein show increased stability in sera and augmented transduction of primary lymphocytes and CD34+ cells derived from human and nonhuman primates. Blood 100:823–832.
Hanawa, H., P.F. Kelly, A.C. Nathwani, D.A. Persons, J.A. Vandergriff, P. Hargrove, E.F. Vanin and A.W. Nienhuis. 2002. Comparison of various envelope proteins for their ability to pseudotype lentiviral vectors and transduce primitive hematopoietic cells from human blood. Mol Ther 5:242–251.
Schambach, A., M. Galla, U. Modlich, E. Will, S. Chandra, L. Reeves, M. Colbert, D.A. Williams, et al. 2006. Lentiviral vectors pseudotyped with murine ecotropic envelope: increased biosafety and convenience in preclinical research. Exp Hematol 34:588–592.
Zack, J.A., S.J. Arrigo, S.R. Weitsman, A.S. Go, A. Haislip and I.S. Chen. 1990. HIV-1 entry into quiescent primary lymphocytes: molecular analysis reveals a labile, latent viral structure. Cell 61:213–222.
Unutmaz, D., V.N. KewalRamani, S. Marmon and D.R. Littman. 1999. Cytokine signals are sufficient for HIV-1 infection of resting human T lymphocytes. J Exp Med 189:1735–1746.
Neil, S., F. Martin, Y. Ikeda and M. Collins. 2001. Postentry restriction to human immunodeficiency virus-based vector transduction in human monocytes. J Virol 75:5448–5456.
Sirven, A., E. Ravet, P. Charneau, V. Zennou, L. Coulombel, D. Guetard, F. Pflumio and A. Dubart-Kupperschmitt. 2001. Enhanced transgene expression in cord blood CD34(+)-derived hematopoietic cells, including developing T cells and NOD/SCID mouse repopulating cells, following transduction with modified trip lentiviral vectors. Mol Ther 3:438–448.
Muhlebach, M.D., N. Wolfrum, S. Schule, U. Tschulena, R. Sanzenbacher, E. Flory, K. Cichutek and M. Schweizer. 2005. Stable transduction of primary human monocytes by simian lentiviral vector PBj. Mol Ther 12:1206–1216.
Mangeot, P.E., D. Negre, B. Dubois, A.J. Winter, P. Leissner, M. Mehtali, D. Kaiserlian, F.L. Cosset, et al. 2000. Development of minimal lentivirus vectors derived from simian immunodeficiency virus (SIVmac251) and their use for gene transfer into human dendritic cells. J Virol 74:8307–8315.
Negre, D., P.E. Mangeot, G. Duisit, S. Blanchard, P.O. Vidalain, P. Leissner, A.J. Winter, C. Rabourdin-Combe, et al. 2000. Characterization of novel safe lentiviral vectors derived from simian immunodeficiency virus (SIVmac251) that efficiently transduce mature human dendritic cells. Gene Ther 7:1613–1623.
Schnell, T., P. Foley, M. Wirth, J. Munch and K. Uberla. 2000. Development of a self-inactivating, minimal lentivirus vector based on simian immunodeficiency virus. Hum Gene Ther 11:439–447.
Hanawa, H., P. Hematti, K. Keyvanfar, M.E. Metzger, A. Krouse, R.E. Donahue, S. Kepes, J. Gray, et al. 2004. Efficient gene transfer into rhesus repopulating hematopoietic stem cells using a simian immunodeficiency virus-based lentiviral vector system. Blood 103:4062–4069.
Dupuy, F.P., E. Mouly, M. Mesel-Lemoine, C. Morel, J. Abriol, M. Cherai, C. Baillou, D. Negre, et al. 2005. Lentiviral transduction of human hematopoietic cells by HIV-1- and SIV-based vectors containing a bicistronic cassette driven by various internal promoters. J Gene Med 7:1158–1171.
Poeschla, E.M., F. Wong-Staal and D.J. Looney. 1998. Efficient transduction of nondividing human cells by feline immunodeficiency virus lentiviral vectors. Nat Med 4:354–357.
Serafini, M., L. Naldini and M. Introna. 2004. Molecular evidence of inefficient transduction of proliferating human B lymphocytes by VSV-pseudotyped HIV-1-derived lentivectors. Virology 325:413–424.
Janssens, W., M.K. Chuah, L. Naldini, A. Follenzi, D. Collen, J.M. Saint-Remy and T. VandenDriessche. 2003. Efficiency of onco-retroviral and lentiviral gene transfer into primary mouse and human B-lymphocytes is pseudotype dependent. Hum Gene Ther 14:263–276.
Bovia, F., P. Salmon, T. Matthes, K. Kvell, T.H. Nguyen, C. Werner-Favre, M. Barnet, M. Nagy, et al. 2003. Efficient transduction of primary human B lymphocytes and nondividing myeloma B cells with HIV-1-derived lentiviral vectors. Blood 101:1727–1733.
Kvell, K., T.H. Nguyen, P. Salmon, F. Glauser, C. Werner-Favre, M. Barnet, P. Schneider, D. Trono, et al. 2005. Transduction of CpG DNA-stimulated primary human B cells with bicistronic lentivectors. Mol Ther 12:892–899.
Marshall, J.D., K. Fearon, C. Abbate, S. Subramanian, P. Yee, J. Gregorio, R.L. Coffman and G. Van Nest. 2003. Identification of a novel CpG DNA class and motif that optimally stimulate B cell and plasmacytoid dendritic cell functions. J Leukoc Biol 73:781–792.
Dyall, J., J.B. Latouche, S. Schnell and M. Sadelain. 2001. Lentivirus-transduced human monocyte-derived dendritic cells efficiently stimulate antigen-specific cytotoxic T lymphocytes. Blood 97:114–121.
Rouas, R., R. Uch, Y. Cleuter, F. Jordier, C. Bagnis, P. Mannoni, P. Lewalle, P. Martiat, et al. 2002. Lentiviral-mediated gene delivery in human monocyte-derived dendritic cells: optimized design and procedures for highly efficient transduction compatible with clinical constraints. Cancer Gene Ther 9:715–724.
Lizee, G., M.I. Gonzales and S.L. Topalian. 2004. Lentivirus vector-mediated expression of tumor-associated epitopes by human antigen presenting cells. Hum Gene Ther 15:393–404.
Uphoff, C.C., C. Meyer and H.G. Drexler. 2002. Elimination of mycoplasma from leukemia-lymphoma cell lines using antibiotics. Leukemia 16:284–288.
Kustikova, O.S., A. Wahlers, K. Kuhlcke, B. Stahle, A.R. Zander, C. Baum and B. Fehse. 2003. Dose finding with retroviral vectors: correlation of retroviral vector copy numbers in single cells with gene transfer efficiency in a cell population. Blood 102:3934–3937.
Mostoslavsky, G., D.N. Kotton, A.J. Fabian, J.T. Gray, J.S. Lee and R.C. Mulligan. 2005. Efficiency of transduction of highly purified murine hematopoietic stem cells by lentiviral and oncoretroviral vectors under conditions of minimal in vitro manipulation. Mol Ther 11:932–940.
Ferrand, C., E. Robinet, E. Contassot, J.M. Certoux, A. Lim, P. Herve and P. Tiberghien. 2000. Retrovirus-mediated gene transfer in primary T lymphocytes: influence of the transduction/selection process and of ex vivo expansion on the T cell receptor beta chain hypervariable region repertoire. Hum Gene Ther 11:1151–1164.
He, Y., J. Zhang, Z. Mi, P. Robbins and L.D. Falo, Jr. 2005. Immunization with lentiviral vector-transduced dendritic cells induces strong and long-lasting T cell responses and therapeutic immunity. J Immunol 174:3808–3817.
Schambach, A., H. Wodrich, M. Hildinger, J. Bohne, H.G. Krausslich and C. Baum. 2000. Context dependence of different modules for posttranscriptional enhancement of gene expression from retroviral vectors. Mol Ther 2:435–445.
Donello, J.E., J.E. Loeb and T.J. Hope. 1998. Woodchuck hepatitis virus contains a tripartite posttranscriptional regulatory element. J Virol 72:5085–5092.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2008 Humana Press Inc.
About this protocol
Cite this protocol
Swainson, L., Mongellaz, C., Adjali, O., Vicente, R., Taylor, N. (2008). Lentiviral Transduction of Immune Cells. In: Ewbank, J., Vivier, E. (eds) Innate Immunity. Methods in Molecular Biology™, vol 415. Humana Press. https://doi.org/10.1007/978-1-59745-570-1_18
Download citation
DOI: https://doi.org/10.1007/978-1-59745-570-1_18
Publisher Name: Humana Press
Print ISBN: 978-1-58829-746-4
Online ISBN: 978-1-59745-570-1
eBook Packages: Springer Protocols